JP2023546742A5 - - Google Patents
Info
- Publication number
- JP2023546742A5 JP2023546742A5 JP2023548994A JP2023548994A JP2023546742A5 JP 2023546742 A5 JP2023546742 A5 JP 2023546742A5 JP 2023548994 A JP2023548994 A JP 2023548994A JP 2023548994 A JP2023548994 A JP 2023548994A JP 2023546742 A5 JP2023546742 A5 JP 2023546742A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- independently selected
- alkyl
- substituted
- appropriately substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/122794 | 2020-10-22 | ||
| CN2020122794 | 2020-10-22 | ||
| CN2021113042 | 2021-08-17 | ||
| CNPCT/CN2021/113042 | 2021-08-17 | ||
| CN2021122851 | 2021-10-09 | ||
| CNPCT/CN2021/122851 | 2021-10-09 | ||
| PCT/CN2021/125409 WO2022083703A1 (en) | 2020-10-22 | 2021-10-21 | Compounds and compositions for treating conditions associated with lpa receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546742A JP2023546742A (ja) | 2023-11-07 |
| JP2023546742A5 true JP2023546742A5 (https=) | 2024-10-29 |
Family
ID=78516438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548994A Pending JP2023546742A (ja) | 2020-10-22 | 2021-10-21 | Ｌｐａ受容体活性に付随する症状を治療するための化合物および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240018102A1 (https=) |
| EP (2) | EP4232431B1 (https=) |
| JP (1) | JP2023546742A (https=) |
| CN (1) | CN116583501A (https=) |
| ES (1) | ES3049795T3 (https=) |
| TW (1) | TW202233575A (https=) |
| WO (1) | WO2022083703A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4419509A4 (en) * | 2021-10-21 | 2025-10-15 | Lhotse Bio Inc | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY |
| TW202342017A (zh) | 2022-02-25 | 2023-11-01 | 美商洛子峰生物有限公司 | 用於治療與ｌｐａ受體活性相關的病狀的化合物及組合物 |
| WO2026002179A1 (en) * | 2024-06-28 | 2026-01-02 | Rezubio Pharmaceuticals Co., Ltd | Compounds and compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820682B2 (en) * | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| ATE528276T1 (de) * | 2003-12-19 | 2011-10-15 | Ono Pharmaceutical Co | Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen |
| CN101119714A (zh) * | 2005-02-14 | 2008-02-06 | 弗吉尼亚大学专利基金会 | 含有由氨基和苯基取代的环烷基和5元杂环的1-磷酸鞘氨醇激动剂 |
| JP2014525932A (ja) * | 2011-08-15 | 2014-10-02 | インターミューン， インコーポレイテッド | リゾホスファチド酸レセプターアンタゴニスト |
| AR108838A1 (es) * | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| CN111712492B (zh) * | 2017-12-19 | 2024-05-31 | 百时美施贵宝公司 | 作为lpa拮抗剂的环己基酸三唑唑类 |
| US11447475B2 (en) * | 2017-12-19 | 2022-09-20 | Bristol-Myers Squibb Company | Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists |
-
2021
- 2021-10-21 CN CN202180081636.1A patent/CN116583501A/zh active Pending
- 2021-10-21 JP JP2023548994A patent/JP2023546742A/ja active Pending
- 2021-10-21 EP EP21802197.0A patent/EP4232431B1/en active Active
- 2021-10-21 US US18/033,306 patent/US20240018102A1/en active Pending
- 2021-10-21 WO PCT/CN2021/125409 patent/WO2022083703A1/en not_active Ceased
- 2021-10-21 ES ES21802197T patent/ES3049795T3/es active Active
- 2021-10-21 EP EP25195382.4A patent/EP4670791A3/en active Pending
- 2021-10-22 TW TW110139351A patent/TW202233575A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546742A5 (https=) | ||
| HRP20241159T1 (hr) | Heterociklički agonisti za glp-1 | |
| JP2024522373A5 (https=) | ||
| JP2021508686A5 (https=) | ||
| RU2415856C2 (ru) | ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ ТЕТРАГИДРОПИРОЛЛО[3,2-c]ПИРИДИН-4-ОНОВЫХ ПРОИЗВОДНЫХ ДЛЯ ЛЕЧЕНИЯ ОЖИРЕНИЯ, ПСИХИАТРИЧЕСКИХ И НЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ | |
| TW202039470A (zh) | 一種THRβ受體激動劑化合物及其製備方法和用途 | |
| JP2022512482A5 (https=) | ||
| RU2012103487A (ru) | Ингибирующие jak соединения на основе пиразолопиримидина и способы | |
| JP6407955B2 (ja) | クマリン誘導体、ならびに過剰増殖疾患を治療する際の使用方法 | |
| JP2023544476A5 (https=) | ||
| JP2019510787A5 (https=) | ||
| JPH07502742A (ja) | Ｐａｆ−レセプタ拮抗剤としてのアミノ酸誘導体 | |
| JP6726640B2 (ja) | 腫瘍転移及び腫瘍形成の予防及び治療のための化合物並びに方法 | |
| RU2006112427A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2010540508A5 (https=) | ||
| JP2022519131A5 (https=) | ||
| JP2024534840A5 (https=) | ||
| JP2023552610A (ja) | 新規カンプトテシン誘導体、それを含む組成物およびその使用 | |
| JP2022529371A5 (https=) | ||
| WO2022100624A1 (zh) | 氧取代氨基碳酸酯噻吩类化合物及其用途 | |
| JP2011519360A5 (https=) | ||
| JP2023516714A (ja) | 新規ｅｐ４拮抗薬の合成及びその癌及び炎症における使用 | |
| WO2019109415A1 (zh) | 一种靶向降解hmgcr的化合物及其应用 | |
| JPH01250372A (ja) | ジ‐ｔｅｒｔ‐ブチルフェノール化合物の環状抗炎症性誘導体 | |
| JP2024502473A5 (https=) |